Clalit study is the first in the world to prove new reformulated Omicron vaccine protects the elderly and immunocompromised from hospitalization and death.
Largest investigation of the new COVID shots suggests they also sharply reduce deaths, calling them ‘an effective and essential tool’; research is not yet peer-reviewed
Jerusalem, Jan 10 (EFE).- New Covid-19 vaccines adapted to the Omicron variant have reduced hospitalizations for the disease among those over 65 by 81 percent, according to research carried out in Israel, a country that pioneered the vaccination campaign during the pandemic. The study, focused on Pfizer’s updated vaccines that launched in the summer, found …
The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients who are ages 65 and older, according to a new study published in The New England Journal of Medicine.